Andreas Lehmann

Andreas Lehmann is an accomplished professional with over 12 years of experience in commercial strategy, market access, business development, and commercial law in Europe, the US, and Greater China.

He holds an MBA from INSEAD and has a diverse educational background including Attorney at Law, Master of Law, and a Bachelor of Law.

Andreas has a track record of helping businesses in pharma, biotech, and medtech expand their market presence in Europe and Asia.

His expertise includes negotiating foreign investment transactions, M&A deals, and driving top- and bottom-line growth.

He is skilled in managing multi-cultural teams, possesses strong communication and people skills, and is fluent in German, English, and French, with business proficiency in Chinese.

Andreas Lehmann's professional journey includes roles such as Director, Regional Accounts, US Managed Markets at Novartis, Senior Engagement Manager at McKinsey & Company, and Director of Pharma Commercial Strategy at Novartis.

He has also been involved as an advisor, investor, and thought partner in various early-stage start-ups and organizations like Antler, Loyal VC, CLEX BIO, and StanPlus.

His passion lies in advancing society through technological innovation, focusing on mega-trends like urbanization, healthcare personalization, biotechnology, AI, big data, and more.

Andreas Lehmann's dedication to commercial progression in these areas showcases his commitment to driving change and growth in the 21st century.